In a report issued on July 12, Daniel Fannon from Jefferies maintained a Buy rating on CME Group (NASDAQ: CME), with a price target of $188. The company’s shares closed on Friday at $166.91, close to its 52-week high of $174.36.
According to TipRanks.com, Fannon is a top 100 analyst with an average return of 15.9% and a 77.2% success rate. Fannon covers the Financial sector, focusing on stocks such as WisdomTree Investments, Gain Capital Holdings, and Federated Investors.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CME Group with a $179.50 average price target.
See today’s analyst top recommended stocks >>
Based on CME Group’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.11 billion and net profit of $599 million. In comparison, last year the company had a net profit of $416 million.
Based on the recent corporate insider activity of 103 insiders, corporate insider sentiment is negative on the stock. Last month, Kathleen Cronin, the Sr MD Gen Counsel & Corp Secr of CME sold 5,320 shares for a total of $876,470.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CME Group, Inc. operates as a security and commodity exchange company. It provides the risk management and investment needs of customers around the globe. The company offers a wide range of products across various asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
